Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002703.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 28.63 1.93 1.50
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 6.98 -5.11 4.77
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 19.88 2.23 1.86
Cash 108.79 0.71 0.34
Capex -90.65 -0.02 < 0.005
Free Cash Flow -41.66 -0.01 0.02
Revenue -26.30 0.60 0.81
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 8.04 0.20 0.19
Operating Margin -17.08 0.04 0.05
ROA -45.07 < 0.005 0.01
ROE -52.19 0.01 0.02
ROIC -41.80 < 0.005 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002703.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002703.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002703.SZ is permitted for members.